Omega Diagnostics Share Discussion Threads

[longshanks] 24/12/2016 19:36

Merry Christmas all ODXers

[hyperboreus] 21/12/2016 20:45

Only interesting buying longshanks if you know who or maybe why they are buying :-)

Anyhow for what it is worth and for all 'Chartist share followers' out there:



It is one month to the day that the interims and approach by IDH were announced so discussions presumably still ongoing.

Hopefully positive news around the corner, Merry Christmas to the 'ODX chosen few' from 'Up North'

[longshanks] 21/12/2016 20:10

Yes - merry Christmas and wishing us all a Happy and prosperous New Year.

[barrywhit] 21/12/2016 18:19

Cheers Leeds, lets hope so. Happy Christmas mate......

[leedslad001] 21/12/2016 17:46

Happy Christmas everyone and I am sure we will have prosperous new year

[longshanks] 21/12/2016 16:34

Some interesting buying today.I note on twitter that ODX is posting images of the Visitect CD4 being used. They are being posted from South Africa and imply that users are being trained in the use of the RDT.

[dibs61] 15/12/2016 14:36

Surprised they got 17.62 tbh. I got quoted 17.5 for a much smaller dummy sell yday

[dibs61] 15/12/2016 14:35

And knocked the share price off its perch in the process. Thanks

[barrywhit] 15/12/2016 13:49

obviously the 100k seller needed some Xmas funds.....

[dibs61] 14/12/2016 15:48

So, we are agreed. A sale of Allersys it is and a resulting significant cash boost for the company eliminating any doubt of dilution being necessary and actually 'creating value for shareholders' that oft used but least delivered phrase on AIM

[supernumerary] 13/12/2016 20:11

JVs are a dreadful idea. Joint ownership means joint responsibility and joint authority. How is that supposed to work effectively? The spoils (if there are any) always go to the stronger party, and the weaker one eventually gives up on it, having wasted time and energy that could have been much better spent elsewhere.

[p1nkfish] 13/12/2016 17:29

Still think JV best way forward with some capital injection into the none JV section for CD4.

[longshanks] 13/12/2016 16:56

I know. Reading that Hardmann note, it does seem their analyst has had a private briefing with the company and garnered far more information than that made available to shareholders.There is a clear need for a cash injection to complete CD4 commercialisation. Hardmann draw the same conclusion I have, that IDH need Allersys and have plenty of cash with which to incentivise a sale by ODX. I wonder how much of this is "inspired speculation" of the analysts or something fed them by Kieron Harbinson as a corporate aspiration.

[longshanks] 13/12/2016 14:59

I note from the Hardmann report that the Visitect CD4 device now has stable operation at 40 DegC.

[longshanks] 09/12/2016 19:23

Sooner rather than later if my water counts for anything ;)

[dibs61] 09/12/2016 11:52

Been reading the Hardman Report again. They point out that ODX trades currently at a discount to NAV. This gives a further indication of how the market is fundamentally undervaluing this company.

The NAV is 19.1p

This means there's effectively no value placed on earnings based on this metric.

If the company was bought out it would be substantially above the current price.

If they sold the allergy business,as Hardman say, it would provide 'substantial resources ' to 'accelerate growth strategy'

Business substantially undervalued. Sooner or later the market will adjust accordingly

[dibs61] 07/12/2016 10:31

I see thanks longshanks.

[longshanks] 05/12/2016 19:59

The 2013 amended agreement made IDH the exclusive distributor of Allersys in certain regions where they have a strong existing presence.This includes Germany.

[barrywhit] 05/12/2016 19:30

Could it be that IDH have exclusivity in Germany???

[dibs61] 05/12/2016 19:06

Sorry longshanks could you explain what you mean in that last sentence? I didn't get the point. Thx

[longshanks] 04/12/2016 21:43

One thing that I didn't notice on first reading of the half year results is that they disclosed in these that the first customer for the Allersys system is German.They didn't mention this detail in the trading update so it got me thinking why it was revealed in the results.Could it be that the significance of it being a German customer have anything to do with the amended license agreement made between IDH and ODX in 2013?

[longshanks] 29/11/2016 08:32

And don't forget they all have "shareholder friendly" options that only vest once the share price reaches 50p.It looks to me like we are reaching a prime price point. Selling into the last "surge" has so far failed to defeat the rise and whilst I'm looking for 20p as the first sign that we are starting a bull run, I am confident the upside now is far ahead of any downside risk.

[barrywhit] 29/11/2016 07:56

hydrus.

According to the Hardman note, Directors hold 5.8%%.....

[p1nkfish] 27/11/2016 00:24

Sneller has a decent record with the likes of PIM, CRX, BANGO and I think SBS if I remember correctly. I made very good returns in CRX, PIM and SBS. I think the same will play out here.